ACTG Launches HIV Cure Study Evaluating Novel Approach Targeting the HIV Reservoir
|
Small trial will test whether dasatinib, an approved
leukemia medication, can help reduce the viral reservoir and enable HIV
remission. |
Misinformation threatens rollout of HIV prevention drug lenacapavir
Health experts say false claims about the lenacapavir injection could undermine efforts to reduce new HIV infections in South Africa. View article...